Prokallikrein in the kidney was partially purified with immunoaffinity and DEAE Sephadex A-50 column chromatographies and its biochemical properties were studied in comparison to three active glandular kallikreins purified from kidney, serum and urine of the rat. The properties of the enzymes obtained by trypsin and α-chymotrypsin activation of prokallikrein were identical with those of active glandular kallikreins from kidney, serum and urine of the rat. Apparent molecular weights of prokallikrein, trypsin-activated kal-likrein, α-chymotrypsin-activated kallikrein, active renal kallikrein and glandular kallikrein in rat serum were 38, 000 and that of active urinary kallikrein was 37, 000. Prokallikrein fraction was activated by trypsin and α-chymotrypsin. But, it was not activated by acidification, kaolin-activated rat serum, plasmin, thrombin, urokinase, rat urinary esterase A, carboxypeptidase B, cathepsin D, elastase, papain and pepsin treatment. Renal kallikrein, purified in the presence of soybean trypsin inhibitor (SBTI), contained 85% prokallikrein, but the enzymatic fraction, purified in the absence of SBTI, contained 23% prokallikrein. Prokallikrein contents of urinary kallikrein and glanddular kallikrein in rat serum were 16% and 20% respectively. These results suggests that prokallikrein is produced in the kidney, exists in the membrane fraction and is activated easily by trypsin-like or chymotrypsin-like enzymes. Prokallikrein activator exists in the kidney tissue, and not in the serum. Since rat serum contained active glandular kallikrein, a part of which may come from kidney, renal kallikrein may play an important role not only to control renal circulation, but also to control the systemic blood pressure.
抄録全体を表示